Laidlaw analyst Yale Jen reiterated a Buy rating and $18.00 price target on Evoke Pharma (NASDAQ: EVOK).The analyst commented, "This ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE